Verrica Pharmaceuticals Inc. - VRCA
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Feb 17, 2026 | SCHEDULE 13G/A | Armistice Capital, LLC | 4.99% | 439,657 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Steven Boyd | 4.99% | 439,657 | View |
| Jan 29, 2026 | SCHEDULE 13G/A | Affinity Asset Advisors, LLC | 5.5% | 884,172 | View |
| Jan 29, 2026 | SCHEDULE 13G/A | Michael Cho | 5.5% | 884,172 | View |
| Dec 30, 2025 | SCHEDULE 13D/A | — | 9.99% | — | View |
| Dec 03, 2025 | SCHEDULE 13G | Affinity Asset Advisors, LLC | 5.47% | 884,172 | View |
| Dec 03, 2025 | SCHEDULE 13G | Affinity Healthcare Fund, LP | 5.47% | 884,172 | View |
| Nov 28, 2025 | SCHEDULE 13D/A | — | 49.9% | 3,958,189 | View |
| Nov 24, 2025 | SCHEDULE 13D | — | 9.99% | — | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Armistice Capital, LLC | 6.77% | 639,193 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Steven Boyd | 6.77% | 639,193 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.